Skip to main content
. 2020 May 15;15(5):e0232985. doi: 10.1371/journal.pone.0232985

Fig 6. Proposed model of CRISPR/Cas9 mediated EGFR knockout in combination with sunitinib and its effect on MAPK signaling pathway in renal cell carcinoma.

Fig 6